← Product Code [JWH](/productcode/JWH) · K962196

# NEXGEN KNEE PROSTHESIS & LEGACY KNEE PROSTHESIS W/CO-NIDIUM SURFACE HARDENING PROCESS (K962196)

_Zimmer, Inc. · JWH · Aug 23, 1996 · Orthopedic · SESE_

**Canonical URL:** https://fda-staging.innolitics.com/device/K962196

## Device Facts

- **Applicant:** Zimmer, Inc.
- **Product Code:** [JWH](/productcode/JWH.md)
- **Decision Date:** Aug 23, 1996
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 888.3560
- **Device Class:** Class 2
- **Review Panel:** Orthopedic
- **Attributes:** Therapeutic

## Indications for Use

Knee femoral components are single use devices implanted in the human knee during total knee arthroplasty. This knee is intended for cement use only.

## Device Story

NexGen and Legacy knee femoral components; cast Zimaloy (Co-Cr-Mo alloy) construction; Co-Nidium surface hardening process for improved wear resistance. Available in left/right configurations; designs include Cruciate Retaining (CR), Posterior Stabilizing (PS, L-PS), Cruciate Retaining Augmentable (CRA), and Constrained Condylar Knee (L-CCK). Options include stem extensions (straight/offset, various lengths/diameters) and surface finishes (precoat, porous, NoCoat). Implanted by orthopedic surgeons during total knee arthroplasty; intended for cemented fixation to restore joint function and reduce wear.

## Clinical Evidence

Bench testing only; performance data demonstrated improved wear resistance of Co-Nidium surface-hardened femoral components compared to non-treated femoral components.

## Technological Characteristics

Material: Cast Zimaloy (Cobalt-Chromium-Molybdenum alloy). Surface treatment: Co-Nidium surface hardening process. Design: Femoral components with various configurations (CR, PS, L-PS, CRA, L-CCK) and stem extension options. Fixation: Cemented only.

## Regulatory Identification

A knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a knee joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and a tibial component or components and a retropatellar resurfacing component made of ultra-high molecular weight polyethylene. This generic type of device is limited to those prostheses intended for use with bone cement (§ 888.3027).

## Predicate Devices

- Cobalt-Chromium Molybdenum Alloy Femoral Heads with Co-Nidium Surface Hardening Process
- MG II® Total Knee System with Ti-Nidium® Surface Hardening Process
- MG II® Porous Total Knee System
- NexGen® Complete Knee Solution
- Legacy™ Knee System

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}

Zimmer
AUG 23 1996
P.O. Box 708
Warsaw, IN 46581-0708
219 267-6131
K962196

# Summary of Safety and Effectiveness

The summary of safety and effectiveness information is submitted in accordance with the requirements of SMDA 1990.

- Submitted by:
Zimmer, Inc.
P.O. Box 708
Warsaw, IN 46581-0708

- Prepared by:
Ruth Ann Wood
Senior Regulatory Affairs Associate

- Date:
June 5, 1996

- Trade Name:
NexGen® Complete Knee Solution with Co-Nidium™ Surface Hardening Process and Legacy™ Knee System with Co-Nidium™ Surface Hardening Process

- Classification:
Class II
21 CFR 888.3530

- Predicate Devices:
Cobalt-Chromium Molybdenum Alloy Femoral Heads with Co-Nidium Surface Hardening Process; MG II® Total Knee System with Ti-Nidium® Surface Hardening Process; MG II® Porous Total Knee System, NexGen® Complete Knee Solution; and the Legacy™ Knee System

- Device Description:
The femorals are made of cast Zimaloy® Cobalt-Chromium-Molybdenum Alloy. They are hardened by the Co-Nidium™ Surface Hardening Process described in

73
A Bristol-Myers Squibb Company

{1}

They are hardened by the Co-Nidium™ Surface Hardening Process described in Section XI. They are available in left and right configurations. NexGen/Legacy Knee femorals cover a multitude of patient specific needs with the Cruciate Retaining (CR), Posterior Stabilizing (PS and L-PS), Cruciate Retaining Augmentable (CRA), and Constrained Condylar Knee (L-CCK) designs. Certain femorals can be augmented with stem extensions. The extensions come in a broad variety of straight and offset shapes as well as numerous lengths and diameters. These femorals will be available in precoat, porous, and option (NoCoat) versions.

- Intended Use:
Knee femoral components are single use devices implanted in the human knee during total knee arthroplasty. This knee is intended for cement use only.

- Performance Data:
The performance data submitted in the 510(k) demonstrated the improved wear resistance compared to nontreated femoral components.

RA05603K.510

74

---

**Source:** [https://fda-staging.innolitics.com/device/K962196](https://fda-staging.innolitics.com/device/K962196)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com
